Jonathan H. Lee, M.D. Medical Director/Surgical Oncologist


Dr. Lee’s experience working with some of the nation’s most renowned cancer institutes, like the John Wayne Cancer Institute and Melanoma and Soft Tissue Program at the Cancer Institute of New Jersey, makes him one of the leading melanoma specialists and surgical oncologists in the Southeast. After receiving his medical degree at New York University School of Medicine, Dr. Lee completed a rigorous general surgery residency at University of Rochester Medical Center. He then completed a surgical oncology fellowship at John Wayne Cancer Institute.

2015-2017

As a top melanoma expert and a translational researcher, Dr. Lee has published several articles on melanoma breakthroughs in distinguished medical journals such as Clinical Cancer Research, Annals of Surgical Oncology, and Journal of Clinical Oncology. Before joining Northside Hospital and establishing Melanoma & Sarcoma Specialists of Georgia, Dr. Lee served as an Assistant Professor of Surgery in the Division of Surgical Oncology at the Robert Wood Johnson Medical School in New Jersey.

 

Current Position

  • Medical Director, Melanoma & Sarcoma Program, Northside Hospital Cancer Institute
  • Chairman, Research Advisory Committee, Northside Hospital Cancer Institute
  • Surgical Oncologist, Melanoma & Sarcoma Specialists of Georgia

Previous Position

  • Assistant Professor of Surgery, Division of Surgical Oncology,
    University of Medicine & Dentistry of New Jersey/ Robert Wood Johnson Medical School
  • Member, Melanoma and Soft Tissue Oncology Program,
    The Cancer Institute of New Jersey (“NCI-Designated Comprehensive Cancer Center”)

Education and Training

  • Fellowship, Surgical Oncology, John Wayne Cancer Institute, 2005
  • Residency, General Surgery, University of Rochester, 2002
  • MD, New York University School of Medicine, 1995
  • BA, Amherst College, 1991

Certifications and Memberships

  • Board Certified, American Board of Surgery
  • Member, Society of Surgical Oncology

Selected Publications

  • Lee JH, Chen Y, Chan JL, Qian Y, Goydos JS. Molecular analysis of melanoma-induced sentinel lymph node immune dysfunction.
    Cancer Immunol Immunother, 60(5):685-92
  • Lee JH, Gulec SA, Kyshtoobayeva A, Sim MS, Morton DL. Biological Factors, Tumor Growth Kinetics, and Survival After Metastasectomy for Pulmonary Melanoma. Ann Surg Oncol, 16(10):2834-9
  • Lee JH, Torisu-Itakura H, Cochran AJ, Kadison A, Huynh Y, Morton DL, Essner R. Quantitative analysis of melanoma-induced cytokine-
    mediated immunosuppression in melanoma sentinel nodes. Clin Cancer Res, 11(1):107-12
  • Lee JH, Essner R, Torisu-Itakura H, Wanek L, Wang H, Morton DL. Factors predictive of tumor-positive non-sentinel lymph nodes
    following tumor positive sentinel lymph node dissection for melanoma. J Clin Oncol, 22(18):3677-3684